查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1840707

颅内动脉瘤市场按治疗类型、动脉瘤位置、患者年龄层和最终用户划分 - 全球预测，2025-2032 年

Intracranial Aneurysm Market by Treatment Type, Aneurysm Location, Patient Age Group, End Users - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，颅内动脉瘤市场规模将达到 83.8 亿美元，复合年增长率为 22.93%。

关键市场统计数据
基准年 2024 16亿美元
预计年份：2025年 19.7亿美元
预测年份 2032 83.8亿美元
复合年增长率 (%) 22.93%

本书全面介绍了颅内动脉瘤治疗中涉及的临床复杂性、诊断进展和多学科治疗路径，这些因素共同重塑了颅内动脉瘤的治疗模式。

颅内动脉瘤的治疗涉及神经外科、血管内治疗、先进影像技术以及不断发展的围手术手术全期护理模式的复杂交叉领域。过去十年间，临床医生和器械研发人员在保留外科手术技术以应对解剖结构复杂的病变的同时，也逐渐转向微创治疗方法。这种融合得益于器械设计和影像解析度的不断改进，从而提高了手术精度和患者选择标准。

当代临床路径强调早期发现、风险分层和多学科治疗计划，整合重症加护、介入性神经放射学和神经外科。高解析度血管影像和动态压力电脑评估等诊断技术的进步，提高了临床医师对病变形态和破裂风险的判断能力。同时，手术流程的改进和围手术全期通讯协定的完善缩短了住院时间和降低了手术全期併发症发生率，从而促进了门诊和混合治疗模式的广泛应用。

儘管技术不断进步，但仍存在诸多障碍。解剖结构的复杂性、患者的合併症以及医疗机构专业水平的差异仍然是影响治疗决策的关键因素。保险报销动态、供应链压力和监管路径也会影响新型医疗器材的推广应用。因此，各相关人员必须权衡临床证据、运作能力和采购实际情况，以优化颅内动脉瘤患者的诊疗服务。

设备、影像和手术策略的快速进步正在推动精准医疗和颅内动脉瘤治疗系统层级变革的新时代。

颅内动脉瘤治疗领域正经历变革性的转变，涵盖器材创新、诊断技术和手术策略等多个面向。器械创新持续朝着低轮廓、柔性结构的方向发展，这些结构能够适应迂曲的神经血管解剖结构，同时提高输送性和促进血管癒合。血流调节和弹簧圈技术的进步改变了治疗流程，使得以往被认为不适合开放性手术的高风险解剖结构也能得到治疗。

随着影像技术的进步和计算工具的整合，诊断技术也得到了显着提升，能够量化动脉瘤壁应力和血流模式。这些改进的诊断方法实现了更精细的风险分层，并指导了介入治疗的时机和方法。在手术操作方面，当解剖特征和先前介入经验决定了每个病例的个人化治疗方法时，结合血管内和显微外科技术的混合方法正被越来越多地采用。

同时，诸如门诊服务的扩展和以价值为导向的医疗模式等系统层面的变革正在重塑医疗服务的提供方式和地点。医疗器材製造商、卓越临床中心和数位医疗创新者之间的伙伴关係正在加速培训、远端原型设计和结果监测方面的迭代改进。这些累积性的转变正在重新定义标准治疗提案，并为那些能够将临床证据与营运准备和采购灵活性相结合的相关人员创造新的机会。

评估2025年美国关税调整如何重塑动脉瘤治疗领域的供应链、采购惯例与临床服务路径

2025年关税政策的实施为颅内动脉瘤治疗的供应链带来了复杂的贸易政策考量。依赖跨境采购植入、特殊金属和精密零件的製造商正面临原物料成本上涨和前置作业时间延长的双重挑战。为此，许多供应商正在重新评估其采购布局，优先考虑供应商多元化以及降低对单一供应商依赖性的协议。

医院采购团队和临床服务提供者正感受到部分设备采购价格上涨以及库存管理日益严格带来的衝击。这些压力促使他们与供应商签订更长期的合同，并更倾向于批量采购以稳定单位成本。此外，与监管合规和海关相关的行政负担也导致补货週期延长，促使医疗机构持有更大的安全库存或评估替代医疗设备方案，以避免手术中断。

从战略层面来看，关税环境正在加速关于近岸外包和区域製造伙伴关係的讨论，这些合作可以减轻关税波动的影响。医疗器材开发商和经销商正在探索本地组装和零件采购，以保持竞争力。同时，临床医生和医院领导者正在重新评估其采购框架，以平衡成本控制和临床质量，优先考虑与那些展现可靠性、本地支援和清晰的上市后监测能力的供应商合作。这些动态正在重塑整个生态系统的商业策略和营运计划。

基于细分市场的洞察分析解释了治疗方式、动脉瘤位置、患者人口统计特征和临床环境如何影响临床路径和应用动态。

分段动态揭示了不同治疗方式、解剖位置、患者群体和治疗环境的差异化采用模式和临床考虑因素：血管内卷取仍然是治疗方法具有血管内通路囊状病变的主要方法；血流导向扩大了宽颈部动脉瘤和动脉瘤样动脉瘤的选择范围，这些动脉瘤需要进行重组；而对于非常复杂的血管分叉结构或需要即时机械排除的病变。

动脉瘤的位置会进一步影响临床决策。前交通动脉、基底动脉、大脑中动脉和后交通动脉的病变会带来独特的技术挑战和破裂风险，进而影响治疗方法、辅助器具的使用以及预期的围手术全期过程。成年患者通常合併多种併发症，这会影响抗血小板治疗方案和装置的选择；老年患者需要仔细权衡手术获益与衰弱相关风险；而儿童患者则需要使用特殊的装置和终身监测策略，以考虑生长发育和长期耐久性。

最终使用者塑造医疗服务模式和资源分配。对于復健轨迹可预测的择期血管内治疗病例，门诊手术中心的重要性日益凸显；诊断中心在早期检测和非侵入性监测途径中发挥关键作用；而医院凭藉其综合重症监护和神经外科能力，仍然是复杂介入治疗和急性破裂处理的主要场所。总而言之，这些细分决定了整个医疗服务过程中的临床路径、采购重点和投资决策。

美洲、欧洲、中东、非洲和亚太地区颅内动脉瘤治疗的临床应用、基础设施投资和就医途径的区域观点

临床实务、法律规范和医疗基础设施的区域差异导致各大全部区域颅内动脉瘤治疗方法的差异化。在美洲，集中化的专科护理、整合的诊疗路径以及日益重视手术疗效的报销模式，促进了先进血管内手术和辅助技术的快速应用。该地区的临床网路和转诊模式通常促使高复杂度病例集中到三级医疗中心，同时允许对部分病例进行门诊手术。

欧洲、中东和非洲地区的情况各不相同：中东和非洲正致力于基础设施建设、培养本地专家并改善诊断影像服务的可近性。监管协调工作和区域采购联盟将影响设备上市时间和定价，製造商需要据此调整打入市场策略。

亚太地区正经历製造业产能的快速扩张、对三级神经血管中心的投资增加，以及部分国家对本土医疗器材研发的重视。某些人群中未确诊脑血管疾病的高发生率促使人们更加关注筛检工作和诊断中心的扩张。在所有地区，跨国合作、临床训练交流和远距指导正日益成为转移诊疗流程和技术的重要机制，从而减少治疗结果的差异，并加速实证医学方法的推广应用。

公司层级的分析重点阐述了现有製造商、专注的创新者以及服务联盟如何重塑设备组合和临床应用轨迹。

公司层面的动态反映了成熟製造商、灵活敏捷的专业公司以及推动创新设备平台和数位辅助设备发展的新兴参与企业的融合。成熟的医疗设备製造商继续利用其全球分销管道、监管经验和丰富的临床证据，支持成熟技术的广泛临床应用。同时，专业公司和新兴企业则专注于差异化的技术优势——例如，新型血流调节结构、促进内皮化的生物活性涂层以及优先考虑在复杂解剖结构中导航的新一代递送系统。

设备开发商与数位医疗服务提供者之间的合作日益普遍，伙伴关係在于高阶影像分析、运算流体建模和上市后结果追踪。这些合作有助于展示设备性能对比，支持临床医生培训，并产生真实世界证据，从而加速医疗机构的采纳。此外，随着医院和门诊中心寻求缩短复杂干预措施的学习曲线，提供端到端培训、远端原型设计和设备支援的服务供应商也越来越受欢迎。

从竞争格局来看，成功的公司将技术差异化与强大的临床数据、积极的监管应对措施以及本地支持能力相结合。那些投资于临床医生教育、实证医学研究和供应链韧性的公司，更有能力应对采购审查，并在高流量中心和新兴治疗领域中保持市场份额。

为医疗器材开发商、医疗服务提供者和支付方提供切实可行的策略建议，以加速创新技术的应用、增强韧性并改善以患者为中心的动脉瘤治疗。

产业领导者应优先采取一系列策略行动，在应对营运和政策限制的同时，充分利用临床创新。首先，将产品开发与经临床医生验证的用例和真实世界证据项目结合，可以减少推广阻力，并向采购委员会展现令人信服的价值提案。与大型临床中心密切合作，进行检验主导的研究、註册登记和培训项目，可以建立持久的信誉，并加速最佳实践的传播。

其次，增强供应链韧性至关重要。领导者应实现采购管道多元化，评估本地组装和近岸外包的机会，并建立灵活的合约安排，包括紧急库存和透明的前置作业时间承诺。这些措施将降低关税主导的成本衝击风险，并增强医疗机构维持正常运作的能力。

第三，投资于能够缩短操作流程学习曲线的培训和服务模式，将有助于在医院和门诊机构中广泛应用。远距指导、模组化培训课程和以结果主导的支援模式可以增强临床医生的信心并减少操作差异。第四，积极与支付方和医疗系统合作，基于临床结果和以患者为中心的指标阐明成本效益，可以使创新应用与报销途径保持一致。最后，为了展现长期价值并支持持续改进，领导者应推行可互通的数位化策略，整合影像分析、结果登记和病患报告结果。

一套透明的调查方法，描述了用于检验研究结果和支持策略建议的综合临床、商业和供应链分析。

本调查方法整合了临床文献回顾、专家访谈、器械标籤和监管文件以及供应链分析，以整体情况组装动脉瘤治疗的动态。关键的定性资料包括对介入性神经放射科医生、神经外科医生、采购负责人和器械设计工程师的结构化访谈，旨在揭示实际应用中的限制因素、技术性能考量以及推动技术应用的因素。这些观点与同行评审的临床研究、操作指南和官方监管文件进行交叉比对，以确保技术准确性和临床相关性。

我们的供应链和政策分析依赖贸易数据、采购案例研究和公开的关税表，以评估近期政策变化如何影响设备可用性和前置作业时间。在适当情况下，我们将基于情境的影响评估纳入我们的方法论，以探索应对供应中断的潜在营运措施，而不做出确定性预测。资料检验步骤包括交叉核对专家回馈和文献证据，以及透过迭代审查来消除分歧并确保我们见解的可靠性。

最终形成的框架强调临床、商业性和营运视角，以支持针对不同相关人员的可操作建议，这些利益相关者包括设备创新者和医院采购团队、临床教育者和政策顾问。

简明扼要的结论整合了临床进展、机构挑战和策略重点，旨在为致力于改善动脉瘤治疗效果和患者可及性的相关人员提供参考。

本分析整合了临床创新、供应链演变和策略影响，全面展现了目前颅内动脉瘤治疗的动态。器械技术和影像技术的进步极大地拓展了治疗选择，而采购压力和贸易政策变化等系统层面的因素则引入了新的运营考量，影响着治疗方案的采纳和普及。这些趋势的交汇凸显了将临床证据的产生与稳健的商业策略和针对性的临床医生支持相结合的重要性。

跨临床、监管和供应链领域协调一致的相关人员最能有效减少干扰，同时加速有益技术的长期应用。透过专注于结果、投资临床医生培训以及实施符合当地实际情况的供应链策略，医疗机构可以保持诊疗流程的连续性并优化患者疗效。总之，推动医疗发展需要製定一项综合计划，在技术创新应用和务实营运管理之间取得平衡，以确保临床进步能够转化为患者照护的实际改善。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 安全性的提升促使血流导向装置在复杂颅内动脉瘤的治疗上得到更广泛的应用。
  • 整合人工智慧驱动的影像平台以提高临床环境中动脉瘤的早期检测率
  • 开发可生物吸收的聚合物涂层神经血管支架，以减少发炎并促进血管癒合
  • 血管内微导管技术的进步使得进入远端和迂曲的脑血管成为可能。
  • 越来越多的临床证据支持使用囊内止血植入治疗宽颈动脉瘤。
  • 针对特定患者的计算流体力学模型在预测动脉瘤破裂风险和治疗反应方面的应用日益广泛。
  • 远距远端医疗的普及使得中风和动脉瘤的追踪通讯协定得以实施，并改善了术后病患监测。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依治疗类型分類的颅内动脉瘤市场

  • 血管内弹簧圈栓塞术
  • 流量转换
  • 手术夹

9. 按动脉瘤位置分類的颅内动脉瘤市场

  • 前交通动脉
  • 基底动脉
  • 大脑中动脉
  • 后交通动脉

第十章 依病患年龄组别分類的颅内动脉瘤市场

  • 成人版
  • 老年人
  • 孩子们

第十一章 以最终用户分類的颅内动脉瘤市场

  • 门诊手术中心
  • 诊断中心
  • 医院

12. 各地区颅内动脉瘤市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 颅内动脉瘤市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国颅内动脉瘤市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Medtronic plc
    • Stryker Corporation
    • Johnson & Johnson
    • Terumo Corporation
    • Boston Scientific Corporation
    • Penumbra, Inc.
    • Abbott Laboratories
Product Code: MRR-A339DAEF9EC7

The Intracranial Aneurysm Market is projected to grow by USD 8.38 billion at a CAGR of 22.93% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.60 billion
Estimated Year [2025] USD 1.97 billion
Forecast Year [2032] USD 8.38 billion
CAGR (%) 22.93%

A comprehensive introduction framing clinical complexity, diagnostic advances, and multidisciplinary care pathways reshaping intracranial aneurysm management

Intracranial aneurysm management occupies a complex intersection of neurosurgery, endovascular therapy, advanced imaging, and evolving perioperative care models. Over the past decade clinicians and device developers have shifted toward minimally invasive approaches while preserving surgical techniques for anatomically challenging lesions. This convergence has been driven by continuous improvements in device design and imaging resolution, which together improve procedural precision and patient selection.

Contemporary clinical pathways emphasize early detection, risk stratification, and interdisciplinary care planning that integrates neurocritical care, interventional neuroradiology, and neurosurgery. Diagnostic advances such as high-resolution vascular imaging and computational assessments of hemodynamic stress have enhanced clinicians' ability to characterize lesion morphology and rupture risk. Meanwhile, procedural refinements and enhanced perioperative protocols have reduced length of stay and perioperative morbidity, supporting broader adoption of ambulatory and hybrid care models.

Despite technological progress, barriers remain. Anatomical complexity, patient comorbidities, and variability of institutional expertise continue to shape treatment decisions. Reimbursement dynamics, supply chain pressures, and regulatory pathways also influence adoption timelines for novel devices. Consequently, strategic stakeholders must reconcile clinical evidence, operational capacity, and procurement realities to optimize care delivery for patients with intracranial aneurysms.

Rapid advancements in devices, imaging, and procedural strategies are catalyzing a new era of precision care and system-level change for intracranial aneurysm treatment

The landscape of intracranial aneurysm care is experiencing transformative shifts that span device innovation, diagnostic sophistication, and procedural strategy. Device innovation continues to favor low-profile, flexible constructs that accommodate tortuous neurovascular anatomy while improving deliverability and vessel healing. Flow modulation technologies and refinements in coil technology have altered therapeutic algorithms, enabling clinicians to treat anatomies that were once considered high risk for open surgery.

Diagnostics have kept pace through enhanced imaging modalities and the integration of computational tools that quantify aneurysm wall stress and flow patterns. These diagnostic improvements enable more granular risk stratification, guiding the timing and modality of intervention. Procedurally, there is growing adoption of hybrid approaches that combine endovascular and microsurgical techniques when anatomy or prior interventions demand a tailored solution.

Concurrently, systems-level changes-such as the expansion of ambulatory procedural settings and greater emphasis on value-based care-are reshaping where and how treatments are delivered. Partnerships between device manufacturers, clinical centers of excellence, and digital health innovators are accelerating iterative improvements in training, remote proctoring, and outcome monitoring. These cumulative shifts are redefining standard-of-care propositions and creating new opportunities for stakeholders who can align clinical evidence with operational readiness and procurement agility.

Assessment of how the 2025 United States tariff adjustments have reshaped supply chains, procurement practices, and clinical delivery pathways in aneurysm care

The tariff measures implemented in 2025 have introduced a complex overlay of trade policy considerations into the supply chains that support intracranial aneurysm care. Manufacturers that rely on cross-border sourcing for implants, specialized metals, and precision components have faced elevated input costs and extended lead times. In response, many suppliers have reevaluated sourcing footprints, prioritizing supplier diversification and contracts that mitigate single-source dependencies.

Hospital procurement teams and clinical service providers have felt the reverberations through higher acquisition prices for select devices and the need for more rigorous inventory management. These pressures have prompted a shift toward longer-term supplier agreements and increased interest in bundled purchasing arrangements to stabilize unit costs. Regulatory compliance and customs-related administrative burdens have also contributed to slower replenishment cycles, encouraging providers to hold larger safety stocks or to qualify alternative device options to avoid procedural interruptions.

At the strategic level, the tariff environment has accelerated conversations about nearshoring and regional manufacturing partnerships that can reduce exposure to tariff volatility. Device developers and distributors are exploring localized assembly and component sourcing to preserve competitiveness. In parallel, clinicians and hospital leaders are reassessing procurement frameworks to balance cost containment with clinical quality, emphasizing vendor partnerships that demonstrate reliability, local support, and clear post-market surveillance capabilities. These dynamics are reshaping commercial strategies and operational planning across the ecosystem.

Segment-driven insights explaining how treatment modalities, aneurysm locations, patient demographics, and clinical settings influence clinical pathways and adoption dynamics

Segment-level dynamics reveal differentiated adoption patterns and clinical considerations across treatment modalities, anatomical locations, patient demographics, and care settings. When analyzed by treatment type-Endovascular Coiling, Flow Diversion, and Surgical Clipping-each modality presents distinct strengths: coiling remains a mainstay for saccular lesions amenable to endovascular access; flow diversion has expanded options for wide-neck and fusiform aneurysms where vessel reconstruction is desirable; and surgical clipping retains importance for complex bifurcation anatomy and ruptured lesions where immediate mechanical exclusion is required.

Aneurysm location further nuances clinical decision making. Lesions arising in the anterior communicating artery, basilar artery, middle cerebral artery, and posterior communicating artery exhibit unique technical challenges and rupture risk profiles, influencing modality selection, adjunct device use, and anticipated perioperative courses. Patient age group segmentation also affects therapeutic strategy: adult patients commonly present with a wider array of comorbidities that influence antiplatelet planning and device choice, geriatric patients require careful balance between procedural benefit and frailty-related risk, and pediatric cases demand specialized devices and lifelong surveillance strategies that account for growth and long-term durability.

End users shape delivery models and resource allocation. Ambulatory Surgery Centers are increasingly relevant for select elective endovascular cases with predictable recovery trajectories, Diagnostic Centers play a pivotal role in early detection and noninvasive surveillance pathways, and Hospitals continue to be the primary site for complex interventions and acute rupture management due to their integrated critical care and neurosurgical capabilities. Taken together, these segmentation lenses inform clinical pathways, procurement priorities, and investment decisions across the continuum of care.

Regional perspectives on clinical adoption, infrastructure investment, and access pathways shaping intracranial aneurysm care across the Americas, EMEA, and Asia-Pacific

Regional variations in clinical practice, regulatory frameworks, and healthcare infrastructure drive differentiated approaches to intracranial aneurysm care across the major geographies. In the Americas, a concentration of specialized centers, integrated care pathways, and reimbursement models that increasingly reward procedural efficacy support rapid adoption of advanced endovascular techniques and ancillary technologies. Clinical networks and referral patterns in this region often facilitate centralization of high-complexity cases in tertiary centers while enabling ambulatory procedural growth for suitable elective cases.

In Europe, Middle East & Africa, heterogeneity is pronounced: Western European systems frequently combine strong clinical trial ecosystems with well-established neurointerventional programs, whereas segments of the Middle East and Africa are focused on building infrastructure, training local specialists, and improving access to diagnostic imaging. Regulatory harmonization efforts and regional procurement consortia influence device introduction timelines and pricing dynamics, prompting manufacturers to tailor market entry strategies accordingly.

The Asia-Pacific region demonstrates rapid capacity expansion, investment in tertiary neurovascular centers, and a strong emphasis on domestic device development in some countries. A high burden of undiagnosed cerebrovascular disease in certain populations has heightened focus on screening initiatives and diagnostic center expansion. Across all regions, cross-border collaborations, clinical training exchanges, and remote proctoring are increasingly important mechanisms for transferring technique and technology, thereby reducing variability in outcomes and accelerating uptake of evidence-based approaches.

Company-level analysis highlighting how established manufacturers, focused innovators, and service partnerships are reshaping device portfolios and clinical adoption trajectories

Company-level dynamics reflect a blend of entrenched manufacturers, agile specialist firms, and new entrants pushing on innovative device platforms and digital adjuncts. Established medical device companies continue to leverage global distribution channels, regulatory experience, and extensive clinical evidence to support broad clinical adoption of staple technologies. At the same time, specialized firms and startups concentrate on differentiated technical advantages-such as novel flow modulation architectures, bioactive coatings that promote endothelialization, and next-generation delivery systems that prioritize navigability in tortuous anatomy.

Collaborations between device developers and digital health providers are becoming more prevalent, with partnerships focused on advanced imaging analytics, computational fluid modeling, and post-market outcome tracking. These arrangements help demonstrate comparative performance, support clinician training, and generate real-world evidence that can accelerate institutional adoption. In addition, service providers offering end-to-end training, remote proctoring, and device support are gaining prominence as hospitals and ambulatory centers seek to reduce learning curve barriers for complex interventions.

Across the competitive landscape, successful firms combine technical differentiation with robust clinical data, proactive regulatory engagement, and local support capabilities. Companies that invest in clinician education, evidence generation, and supply chain resilience are better positioned to navigate procurement scrutiny and to sustain uptake within high-volume centers as well as emerging treatment sites.

Practical strategic recommendations for device developers, providers, and payers to accelerate innovation adoption, enhance resilience, and improve patient-centered aneurysm care

Industry leaders should prioritize a set of strategic actions to capitalize on clinical innovation while addressing operational and policy constraints. First, aligning product development with clinician-validated use cases and real-world evidence programs will reduce adoption friction and generate compelling value propositions for procurement committees. Close collaboration with high-volume clinical centers for investigator-initiated studies, registries, and training programs can create durable credibility and accelerate dissemination of best practices.

Second, strengthening supply chain resilience is essential. Leaders should diversify sourcing, evaluate regional assembly or nearshoring opportunities, and establish flexible contracting arrangements that include contingency inventory and transparent lead-time commitments. These steps reduce exposure to tariff-driven cost shocks and enhance the ability to support procedural continuity at provider sites.

Third, investing in training and service models that lower procedural learning curves will facilitate broader adoption across hospitals and ambulatory settings. Remote proctoring, modular training curricula, and outcome-driven support models can increase clinician confidence and reduce procedural variability. Fourth, engaging proactively with payers and health systems to articulate cost-effectiveness narratives grounded in clinical outcomes and patient-centered metrics will help align reimbursement pathways with innovation adoption. Finally, leaders should pursue interoperable digital strategies that integrate imaging analytics, outcome registries, and patient-reported outcomes to demonstrate long-term value and support continuous improvement.

Transparent research methodology describing integrated clinical, commercial, and supply chain analyses used to validate insights and support strategic recommendations

The research synthesis draws on a multi-modal methodology that integrates clinical literature review, expert interviews, device labeling and regulatory documentation, and supply chain analyses to assemble a holistic view of intracranial aneurysm care dynamics. Primary qualitative inputs include structured interviews with interventional neuroradiologists, neurosurgeons, procurement leaders, and device design engineers to surface real-world constraints, technology performance considerations, and adoption drivers. These perspectives were triangulated with peer-reviewed clinical studies, procedural guidelines, and public regulatory filings to ensure technical accuracy and clinical relevance.

Supply chain and policy analyses relied on trade data, procurement case studies, and publicly available tariff schedules to assess how recent policy shifts influence device availability and lead times. Where appropriate, the methodology incorporated scenario-based impact assessments to explore potential operational responses to supply disruptions, without producing deterministic forecasts. Data validation steps included cross-referencing expert feedback with documentary evidence, and iterative review cycles to reconcile divergent views and ensure robustness of insights.

The result is a framework that emphasizes clinical, commercial, and operational lenses and that supports actionable recommendations tailored to diverse stakeholders, from device innovators and hospital procurement teams to clinician educators and policy advisors.

Concise conclusion that integrates clinical progress, systemic challenges, and strategic priorities for stakeholders committed to improving aneurysm outcomes and access

This analysis synthesizes clinical innovation, supply chain evolution, and strategic implications to present a cohesive view of current intracranial aneurysm care dynamics. Advances in device technology and imaging have materially expanded therapeutic options, while system-level forces-such as procurement pressures and trade policy shifts-have introduced new operational considerations that affect adoption and access. The intersection of these trends underscores the importance of aligning clinical evidence generation with resilient commercial strategies and targeted clinician support.

Stakeholders who coordinate across clinical, regulatory, and supply chain domains will be best positioned to accelerate durable adoption of beneficial technologies while mitigating disruption. Emphasizing outcomes, investing in clinician training, and pursuing regionally informed supply chain strategies will help institutions maintain procedural continuity and optimize patient outcomes. In sum, the path forward requires integrated planning that balances innovation uptake with pragmatic operational controls, thereby ensuring that clinical advances translate into tangible improvements in patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of flow diverter devices for complex intracranial aneurysm treatment due to improved safety profiles
  • 5.2. Integration of artificial intelligence driven imaging platforms to improve early aneurysm detection rates in clinical practice
  • 5.3. Development of bioresorbable polymer coated neurovascular stents for reduced inflammation and vessel healing
  • 5.4. Advances in endovascular microcatheter technology enabling access to distal and tortuous cerebral vessels
  • 5.5. Growing clinical evidence supporting intrasaccular flow disruption implants for wide neck aneurysm management
  • 5.6. Emergence of patient specific computational fluid dynamics modeling to predict aneurysm rupture risk and treatment response
  • 5.7. Expansion of telemedicine enabled stroke and aneurysm follow up protocols to improve post procedural patient monitoring

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intracranial Aneurysm Market, by Treatment Type

  • 8.1. Endovascular Coiling
  • 8.2. Flow Diversion
  • 8.3. Surgical Clipping

9. Intracranial Aneurysm Market, by Aneurysm Location

  • 9.1. Anterior Communicating Artery
  • 9.2. Basilar Artery
  • 9.3. Middle Cerebral Artery
  • 9.4. Posterior Communicating Artery

10. Intracranial Aneurysm Market, by Patient Age Group

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Intracranial Aneurysm Market, by End Users

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals

12. Intracranial Aneurysm Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Intracranial Aneurysm Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intracranial Aneurysm Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Medtronic plc
    • 15.3.2. Stryker Corporation
    • 15.3.3. Johnson & Johnson
    • 15.3.4. Terumo Corporation
    • 15.3.5. Boston Scientific Corporation
    • 15.3.6. Penumbra, Inc.
    • 15.3.7. Abbott Laboratories

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRACRANIAL ANEURYSM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANTERIOR COMMUNICATING ARTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANTERIOR COMMUNICATING ARTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANTERIOR COMMUNICATING ARTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANTERIOR COMMUNICATING ARTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANTERIOR COMMUNICATING ARTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANTERIOR COMMUNICATING ARTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY BASILAR ARTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY BASILAR ARTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY BASILAR ARTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY BASILAR ARTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY BASILAR ARTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY BASILAR ARTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY MIDDLE CEREBRAL ARTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY MIDDLE CEREBRAL ARTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY MIDDLE CEREBRAL ARTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY MIDDLE CEREBRAL ARTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY MIDDLE CEREBRAL ARTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY MIDDLE CEREBRAL ARTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY POSTERIOR COMMUNICATING ARTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY POSTERIOR COMMUNICATING ARTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY POSTERIOR COMMUNICATING ARTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY POSTERIOR COMMUNICATING ARTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY POSTERIOR COMMUNICATING ARTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY POSTERIOR COMMUNICATING ARTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 95. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 97. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 99. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 108. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 112. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 118. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 122. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 133. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 148. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 152. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 153. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 158. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 159. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 162. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 180. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 181. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 184. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 185. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 190. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 191. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 194. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 205. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 210. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 211. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 214. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 215. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 220. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 221. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 224. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 225. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 230. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 231. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 234. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 240. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 241. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 245. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 248. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 249. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 252. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 253. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 256. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 257. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 260. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 261. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 264. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 265. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 268. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 272. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 273. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 277. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 280. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 281. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 284. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 285. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 288. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 289. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 292. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 293. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 296. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 297. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 298. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 299. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 300. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 301. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 304. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 305. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 308. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 309. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 312. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 313. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 314. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 315. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 316. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 317. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 320. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 321. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 322. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 323. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 324. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 325. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 328. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 329. IND